133 related articles for article (PubMed ID: 29191657)
1. Extracellular vesicle-encapsulated microRNA-761 enhances pazopanib resistance in synovial sarcoma.
Shiozawa K; Shuting J; Yoshioka Y; Ochiya T; Kondo T
Biochem Biophys Res Commun; 2018 Jan; 495(1):1322-1327. PubMed ID: 29191657
[TBL] [Abstract][Full Text] [Related]
2. Pazopanib-induced changes in protein expression signatures of extracellular vesicles in synovial sarcoma.
Shiozawa K; Yoshioka Y; Qiao Z; Shuting J; Ochiya T; Kondo T
Biochem Biophys Res Commun; 2018 Nov; 506(3):723-730. PubMed ID: 30454707
[TBL] [Abstract][Full Text] [Related]
3. Activation of ERK1/2 Causes Pazopanib Resistance via Downregulation of DUSP6 in Synovial Sarcoma Cells.
Yokoyama N; Matsunobu T; Matsumoto Y; Fukushi JI; Endo M; Hatano M; Nabeshima A; Fukushima S; Okada S; Iwamoto Y
Sci Rep; 2017 Mar; 7():45332. PubMed ID: 28350009
[TBL] [Abstract][Full Text] [Related]
4. SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1.
Minami Y; Kohsaka S; Tsuda M; Yachi K; Hatori N; Tanino M; Kimura T; Nishihara H; Minami A; Iwasaki N; Tanaka S
Cancer Sci; 2014 Sep; 105(9):1152-9. PubMed ID: 24989082
[TBL] [Abstract][Full Text] [Related]
5. A novel multi-kinase inhibitor pazopanib suppresses growth of synovial sarcoma cells through inhibition of the PI3K-AKT pathway.
Hosaka S; Horiuchi K; Yoda M; Nakayama R; Tohmonda T; Susa M; Nakamura M; Chiba K; Toyama Y; Morioka H
J Orthop Res; 2012 Sep; 30(9):1493-8. PubMed ID: 22359392
[TBL] [Abstract][Full Text] [Related]
6. Proteomic approach toward determining the molecular background of pazopanib resistance in synovial sarcoma.
Qiao Z; Shiozawa K; Kondo T
Oncotarget; 2017 Dec; 8(65):109587-109595. PubMed ID: 29312631
[TBL] [Abstract][Full Text] [Related]
7. Identification of altered MicroRNA expression patterns in synovial sarcoma.
Hisaoka M; Matsuyama A; Nagao Y; Luan L; Kuroda T; Akiyama H; Kondo S; Hashimoto H
Genes Chromosomes Cancer; 2011 Mar; 50(3):137-45. PubMed ID: 21213367
[TBL] [Abstract][Full Text] [Related]
8. Adaptor protein Crk induces Src-dependent activation of p38 MAPK in regulation of synovial sarcoma cell proliferation.
Watanabe T; Tsuda M; Tanaka S; Ohba Y; Kawaguchi H; Majima T; Sawa H; Minami A
Mol Cancer Res; 2009 Sep; 7(9):1582-92. PubMed ID: 19737974
[TBL] [Abstract][Full Text] [Related]
9. The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.
Nakamura T; Matsumine A; Kawai A; Araki N; Goto T; Yonemoto T; Sugiura H; Nishida Y; Hiraga H; Honoki K; Yasuda T; Boku S; Sudo A; Ueda T
Cancer; 2016 May; 122(9):1408-16. PubMed ID: 26970174
[TBL] [Abstract][Full Text] [Related]
10. Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse model.
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Nelson SD; Russell TA; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Higuchi T; Singh SR; Tsuchiya H; Hoffman RM
Tissue Cell; 2019 Jun; 58():107-111. PubMed ID: 31133237
[TBL] [Abstract][Full Text] [Related]
11. SRC signaling is crucial in the growth of synovial sarcoma cells.
Michels S; Trautmann M; Sievers E; Kindler D; Huss S; Renner M; Friedrichs N; Kirfel J; Steiner S; Endl E; Wurst P; Heukamp L; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Cancer Res; 2013 Apr; 73(8):2518-28. PubMed ID: 23580575
[TBL] [Abstract][Full Text] [Related]
12. Response to pazopanib in two pediatric patients with pretreated relapsing synovial sarcoma.
Casanova M; Basso E; Magni C; Bergamaschi L; Chiaravalli S; Carta R; Tirtei E; Massimino M; Fagioli F; Ferrari A
Tumori; 2017 Jan; 103(1):e1-e3. PubMed ID: 27647230
[TBL] [Abstract][Full Text] [Related]
13. Primary Pleural Synovial Sarcoma Treated with Pazopanib.
Sugitani A; Asai K; Kojima K; Eguchi Y; Kawaguchi T; Ohsawa M; Hirata K
Intern Med; 2015; 54(16):2051-5. PubMed ID: 26278301
[TBL] [Abstract][Full Text] [Related]
14. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
[TBL] [Abstract][Full Text] [Related]
15. Promising management of pazopanib-induced liver toxicity.
Vlenterie M; van Erp NP; van der Graaf WT
Acta Oncol; 2015 Jul; 54(7):1064-6. PubMed ID: 25734660
[No Abstract] [Full Text] [Related]
16. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapeutic targets for synovial sarcoma.
Palmerini E; Paioli A; Ferrari S
Expert Rev Anticancer Ther; 2014 Jul; 14(7):791-806. PubMed ID: 24661286
[TBL] [Abstract][Full Text] [Related]
18. The role of TLE1 in synovial sarcoma.
Seo SW; Lee H; Lee HI; Kim HS
J Orthop Res; 2011 Jul; 29(7):1131-6. PubMed ID: 21319215
[TBL] [Abstract][Full Text] [Related]
19. The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth.
Grunewald TG; Willier S; Janik D; Unland R; Reiss C; Prazeres da Costa O; Buch T; Dirksen U; Richter GH; Neff F; Burdach S; Butt E
Biol Cell; 2013 Nov; 105(11):535-47. PubMed ID: 24033704
[TBL] [Abstract][Full Text] [Related]
20. Identification of a blood-borne miRNA signature of synovial sarcoma.
Fricke A; Ullrich PV; Heinz J; Pfeifer D; Scholber J; Herget GW; Hauschild O; Bronsert P; Stark GB; Bannasch H; Eisenhardt SU; Braig D
Mol Cancer; 2015 Aug; 14():151. PubMed ID: 26250552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]